Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06887764 · ClinicalTrials.gov registry record · NA
Robotic Knee Orthosis-assisted Walking in CP
A NA study of Cerebral Palsy (CP) and Crouch Gait, sponsored by Hospital for Special Surgery, New York.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06887764: Recruiting NA study of Cerebral Palsy (CP) and Crouch Gait, sponsored by Hospital for Special Surgery, New York.
NCT06887764 is a NA study of Cerebral Palsy (CP) and Crouch Gait that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 10 participants, below the 29-participant average among 7 other Cerebral Palsy (CP) trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06887764, a NA study of Cerebral Palsy (CP) and Crouch Gait, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Robotic exoskeletons are becoming increasingly accepted to provide upright mobility in individuals with neurological disorders. These devices can assist in overcoming gravitational forces and reduce energy consumption. Agilik is one such device intended for children with neurological disorders. However, Agilik is relatively new, and its efficacy in children with CP is unknown. Therefore, this study aims to assess the effectiveness of Agilik as an assistive device for children with CP and crouch gait. In this pilot study, ten children with CP, GMFCS level II, and crouch gait will walk with Agilik under the supervision of a physical therapist. Assessments of walking with AFO and Agilik will evaluate the efficacy of the device. The pilot study will assess if Agilik decreases crouch and improves gait characteristics in children with CP.
Primary Outcome
The distance covered by participants during a two-minute walking test (2MWT) will be compared between RKO-assisted and shod conditions.
Conditions Studied
Interventions
- DEVICE RKO-assisted walking in children with CP
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-02-10 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06887764 shows while recruiting
NCT06887764 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 29-participant average among 7 other Cerebral Palsy (CP) trials with a reported enrollment target (66% lower).
The record links to 2 conditions, with Cerebral Palsy (CP) appearing as the primary indexed condition, and to 1 intervention - of which RKO-assisted walking in children with CP is the first listed.
NCT06887764 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06887764 about?
NCT06887764 is a clinical study titled "Robotic Knee Orthosis-assisted Walking in CP". Robotic exoskeletons are becoming increasingly accepted to provide upright mobility in individuals with neurological disorders. These devices can assist in overcoming gravitational forces and reduce energy consumption. Agilik is one such device intended for children with neurological disorders. Howe...
What is the current status of trial NCT06887764?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-02-10. Estimated completion is 2026-12.
What conditions does trial NCT06887764 study?
This clinical trial studies the following conditions: Cerebral Palsy (CP), Crouch Gait.
What interventions are being tested in trial NCT06887764?
The interventions under investigation include: RKO-assisted walking in children with CP (DEVICE).
Who is sponsoring clinical trial NCT06887764?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06887764 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy (CP)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Activities-based Locomotor Training in Children With Cerebral Palsy
RECRUITING · NA
-
Speech and Arm Combined Exergame
RECRUITING · NA
-
WBV and Serial Casting for Children with Cerebral Palsy
RECRUITING · NA
-
Effect of a Humanoid Robot With Virtual Reality Games to Train Arm Function in Children With Cerebral Palsy - THRIVE Trial
RECRUITING · NA
-
Pediatric Teleneuromodulation
COMPLETED · NA
-
Cerebral Palsy: Ankle Foot Orthoses - Footwear Combinations
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI